These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Cannabinoid receptors as therapeutic targets in the management of liver diseases. Mallat A; Lotersztajn S Drug News Perspect; 2008 Sep; 21(7):363-8. PubMed ID: 19259549 [TBL] [Abstract][Full Text] [Related]
50. miR-122, a paradigm for the role of microRNAs in the liver. Girard M; Jacquemin E; Munnich A; Lyonnet S; Henrion-Caude A J Hepatol; 2008 Apr; 48(4):648-56. PubMed ID: 18291553 [TBL] [Abstract][Full Text] [Related]
51. Toll-like receptors and adaptor molecules in liver disease: update. Seki E; Brenner DA Hepatology; 2008 Jul; 48(1):322-35. PubMed ID: 18506843 [TBL] [Abstract][Full Text] [Related]
52. NF-kappaB signaling, liver disease and hepatoprotective agents. Sun B; Karin M Oncogene; 2008 Oct; 27(48):6228-44. PubMed ID: 18931690 [TBL] [Abstract][Full Text] [Related]